Skip to content

Long-term quality of life comparison of Billroth-I versus Roux-en-Y reconstruction in radically distal gastrectomy for gastric cancer: a prospective randomized controlled trial

Long-term quality of life comparison of Billroth-I versus Roux-en-Y reconstruction in radically distal gastrectomy for gastric cancer: a prospective randomized controlled trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-10001434
Enrollment
Unknown
Registered
2010-11-24
Start date
2010-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Group A:Billroth-1 reconstruction

Sponsors

West China Hospital, Sichuan University, China
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1) pathologically proven gastric adenocarcinoma, located at lower third of stomach and predictively feasible of distal gastrectomy; 2) predictively resectable diseases, either early or locally advanced gastric cancer, of preoperative staging JGCA 14th Edition cT1N0M0-T4aN2M0, I-IIIb, except T4b; 3) aged between 18 yrs and 75 yrs; 4) no severe comorbidities; 5) WHO performance score <2; 6) no limitation of gender and race; 7) informed consent required.

Exclusion criteria

Exclusion criteria: 1) primary lesion can not be resected in the pattern of distal gastrectomy, but total gastrectomy, Whipple's procedure, or combined organ resection; 2) previous gastric malignancy, such as lymphoma, GIST etc; 3) previous other malignancy; 4) with severe comorbidity, and intolerant of either laparoscopic or open abdominal operation; 5) emergency operation due to hemorrhage or perforation of tumor; 6) comtaminated with neoadjuvant chemoradiotherapy or adjuvant radiotherapy.

Design outcomes

Primary

MeasureTime frame
Complication;EORTC QLQ-STO22;Mortality;EORTC QLQ-C30;

Countries

China

Contacts

Public ContactJian-Kun Hu, M.D., Ph.D.
hujkwch@126.com+86 28 8542878

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026